ScottLawrenceGottliebMD

Dermatology • Exton, PA

Physician

Join to view full profile

Dr. Gottlieb is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gottlieb's full profile

Already have an account?

Office
501 Gordon Dr
Exton, PA 19341
Phone+1 610-594-6660

Fax+1 610-594-6810
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemResidency, Dermatology, 1995 - 1998
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1990 - 1993
Weill Cornell MedicineClass of 1990

Certifications & Licensure

PA State Medical License 1994 - 2024
NY State Medical License 2002 - 2024
NJ State Medical License 1997 - 2023
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FAAD) American Academy of Dermatology
Top MD Consumers Checkbook

Clinical Trials

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis Start of enrollment: 2019 Oct 29
Completed
Phase 3
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) Start of enrollment: 2020 Jun 15
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.
Joel M Gelfand, Daniel B Shin, April W Armstrong, Stephen K Tyring, Andrew Blauvelt, Scott Gottlieb, Benjamin N Lockshin, Robert E Kalb, Robert Fitzsimmons, Justin Rod...> ;JAMA Dermatology. 2022 Dec 1
48 citations
A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S).
Joel M. Gelfand, Daniel B. Shin, Kristina Callis Duffin, April W. Armstrong, Andrew Blauvelt, Stephen K. Tyring, Alan Menter, Scott Gottlieb, Benjamin Lockshin, Eric L...> ;The Journal of Investigative Dermatology. 2020 Sep 1
128 citations
The wrinkle severity rating scale: a validation study.
Doris Day, Curt M. Littler, Richard W. Swift, Scott L. Gottlieb> ;American Journal of Clinical Dermatology. 2004 Jan 1
Breast cancer patients can stop tamoxifen after 5 years.
Scott Gottlieb> ;Western Journal of Medicine. 2001 Jul 1
AMA criticized for calling for condoms in schools.
Scott Gottlieb> ;Western Journal of Medicine. 2000 Mar 1
4 citations
Right-to-die bills defeated in more than 28 states.
Scott Gottlieb> ;Western Journal of Medicine. 1999 Oct 1
NCI defends research involving minority groups.
Scott L. Gottlieb> ;Nature Medicine. 1999 Mar 1
2 citations
Beyond HMOs: Understanding the Next Wave of Change in Health-Care Organization
Scott Gottlieb, Thomas A. Einhorn> ;Journal of The American Academy of Orthopaedic Surgeons. 1998 Mar 1
9 citations
Managed care: form, function, and evolution.
Scott Gottlieb, Thomas A. Einhorn> ;Journal of Bone and Joint Surgery, American Volume. 1997 Jan 1
146 citations
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: A 10-year experience at a sin...
Scott L. Gottlieb, Jonathan T. Wolfe, Floyd E Fox, Barbara J. DeNardo, William H. Macey, Patricia G. Bromley, Stuart R. Lessin, Alain H. Rook> ;Journal of The American Academy of Dermatology. 1996 Dec 1
16 citations
Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infiltration in psoriatic plaques by topical calcitriol
Irene Lu, Patricia Gilleaudeau, John Arthur Mclane, Noah Heftier, Markus Kamber, Scott L. Gottlieb, James G. Krueger, Alice B. Gottlieb> ;Journal of Cutaneous Pathology. 1996 Oct 1
36 citations
Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell‐mediated inflammation are unexpected outcomes
Scott L. Gottlieb, Elizabeth Hayes, Patricia Gilleaudeau, Irma Cardinale, Alice B. Gottlieb, James G. Krueger> ;Journal of Cutaneous Pathology. 1996 Oct 1
33 citations
Reversal of acute renal allograft rejection by extracorporeal photopheresis: A case presentation and review of the literature
Jonathan T. Wolfe, John E. Tomaszewski, Robert A. Grossman, Scott L. Gottlieb, Ali Naji, Kenneth L. Brayman, Sydney M. Kobrin, Alain H. Rook> ;Journal of Clinical Apheresis. 1996 Jan 1
22 citations
Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: A clinical and pathologic study
Scott L. Gottlieb, Noah S Heftler, Patricia Gilleaudeau, Ray Johnson, Val Pierre Vallat, Jonathan Wolfe, Alice B. Gottlieb, James G. Krueger> ;Journal of The American Academy of Dermatology. 1995 Oct 1
438 citations
Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis.
Scott L. Gottlieb, Patricia Gilleaudeau, Ray Johnson, Len Estes, Thasia G. Woodworth, Alice B. Gottlieb, James G. Krueger> ;Nature Medicine. 1995 May 1
Join now to see all

Press Mentions

Stop Personal Care Products from Poisoning Our AirMay 11th, 2018
Algatech Says Despite Concerns About Sunscreen Claims Astaxanthin Can Support Skin HealthJuly 9th, 2018
Sunscreen Pills Work - but Only if You Take Them and Stay InsideAugust 23rd, 2018
Join now to see all